The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

We recently published Jim Cramer Said Allbirds Management Are "Jokers" & Discussed These 18 Stocks. Humana Inc. (NYSE:HUM) is one of the stocks discussed by Jim Cramer.

Humana Inc. (NYSE:HUM) is one of the largest health insurance providers in America. Its shares are down by 31% over the past year and by 26% year-to-date. Barclays discussed the firm’s stock on February 25th as it significantly cut the share price target to $176 from $245 and maintained a Buy rating on the shares. The bank commented that Humana Inc. (NYSE:HUM)’s remarks of Medicare Advantage margins doubling should be viewed with caution. On the 6th, the Trump Administration made a major announcement as it increased Medicare Advantage payments by 2.48% to more than $13 billion in 2027. The announcement led to movement in health insurer stocks, with Humana Inc. (NYSE:HUM)’s shares gaining 11% between the 2nd and the 7th. Naturally, as the announcement was made, Cramer also discussed the health insurance company and remarked that it relied quite a bit on Medicare Advantage:

“Humana and CVS, Humana’s got a big Medicare Advantage business and that stock’s doing quite well”

While we acknowledge the potential of HUM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.